Ann: Q4 2016 Update, page-11

I haven't spent time reading up on the Fuji deal, but like has happened many times with MSB, a forthcoming announcement generates a lot of hype.

I suspect that has been happening with CYP and some may sell thinking they will invest somewhere else until traction has been achieved.

Today's trading should give an idea of what investors think.

I have come to sense the stem cell baby is having a along and painful breech birth and there will be more twists and turns before the science is accepted by mainstream investors.

Once again I'm not up to speed with the RGS and AGC deal.

As an optimist I maintain my hold in the 4 main ASX stem cell companies and have a good chunk in RGS

MSB is my biggest holding by far.